ARTICLE | Financial News
ImmunoCellular amends follow-on
August 8, 2016 7:00 AM UTC
ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif. Business: Cancer Date announced: 2016-08-02 Type: Follow-on To be raised: Up to $20.1 million Shares: 51.5 million Price prior: $0.27 ...